BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9631172)

  • 1. Evidence for presynaptic cholinergic receptors in sympathetic nerves in human dental pulp.
    Parker DA; Marino V; Zisimopoulos S; de la Lande IS
    Arch Oral Biol; 1998 Mar; 43(3):197-204. PubMed ID: 9631172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presynaptic control of noradrenaline release from sympathetic nerves in human dental pulp.
    Parker DA; de la Lande IS; Marino V; Ivar PM
    Arch Oral Biol; 1994 Jan; 39(1):35-41. PubMed ID: 7910015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation by presynaptic beta-adrenoceptors of noradrenaline release from sympathetic nerves in human dental pulp.
    Parker DA; Marino V; Ivar PM; de la Lande IS
    Arch Oral Biol; 1998 Dec; 43(12):949-54. PubMed ID: 9877326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus.
    Karanth S; Lyson K; McCann SM
    Neuroimmunomodulation; 1999; 6(3):168-74. PubMed ID: 10213914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic sprouting: no evidence for muscarinic modulation of noradrenaline release in hippocampal slices of rats with fimbria-fornix lesions.
    Jackisch R; Stemmelin J; Neufang B; Lauth D; Neughebauer B; Kelche C; Cassel JC
    Exp Brain Res; 1999 Jan; 124(1):17-24. PubMed ID: 9928785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic modulation of cholinergic neurotransmission in the human proximal stomach.
    Leclere PG; Lefebvre RA
    Br J Pharmacol; 2002 Jan; 135(1):135-42. PubMed ID: 11786489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinesterase activity and exposure time to acetylcholine as factors influencing the muscarinic inhibition of [3H]-noradrenaline overflow from guinea-pig isolated atria.
    Fuder H; Muscholl E; Wolf K
    Br J Pharmacol; 1985 Dec; 86(4):905-14. PubMed ID: 2866805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between presynaptic facilitatory angiotensin II receptors and inhibitory muscarinic cholinoceptors on 3H-noradrenaline release in the rabbit heart.
    García-Sevilla JA; Dubocovich ML; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jul; 330(1):9-15. PubMed ID: 2995842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-Noradrenaline release from mouse iris-ciliary body: role of presynaptic muscarinic heteroreceptors.
    Bernhard M; Takeda K; Keller C; Haslebacher M; Lambrou GN; Trendelenburg AU
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):305-13. PubMed ID: 15375642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of presynaptic purinoceptors to modulate noradrenaline release from sympathetic nerves in human dental pulp.
    Parker DA; Marino V; Krishna M; Narayanan A; de la Lande IS
    Arch Oral Biol; 2000 Oct; 45(10):827-31. PubMed ID: 10973556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of adrenaline on the release of noradrenaline from sympathetic nerves in human dental pulp.
    Parker DA; Hennian E; Marino V; de la Lande IS
    Arch Oral Biol; 1999 May; 44(5):391-4. PubMed ID: 10391496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
    Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
    Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possibilities for a cholinergic action on smooth musculature and on sympathetic axons in brain vessels mediated by muscarinic and nicotinic receptors.
    Edvinsson L; Falck B; Owman C
    J Pharmacol Exp Ther; 1977 Jan; 200(1):117-26. PubMed ID: 833753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
    Clarke PB; Reuben M
    Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
    Liang SD; Vizi ES
    J Pharmacol Exp Ther; 1997 Feb; 280(2):650-5. PubMed ID: 9023275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of acidosis, high potassium concentrations, and metabolic inhibition on noradrenaline release and its presynaptic muscarinic regulation.
    Haunstetter A; Schulze Icking B; Backs J; Krüger C; Haass M
    Pharmacol Res; 2002 Mar; 45(3):221-8. PubMed ID: 11884219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic inhibition of [3H]-noradrenaline release on rabbit iris in vitro: effects of stimulation conditions on intrinsic activity of methacholine and pilocarpine.
    Bognar IT; Pallas S; Fuder H; Muscholl E
    Br J Pharmacol; 1988 Jul; 94(3):890-900. PubMed ID: 3052680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of endogenous neurotransmitters of guinea pig gallbladder using nicotinic agonist stimulation.
    Parkman HP; Pagano AP; Ryan JP
    Dig Dis Sci; 1998 Oct; 43(10):2237-43. PubMed ID: 9790459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA heteroreceptors modulate noradrenaline release in human dental pulp.
    Parker DA; Marino V
    J Dent Res; 2013 Nov; 92(11):1017-21. PubMed ID: 24056226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prejunctional muscarinic receptor modulation of noradrenaline release from sympathetic neurones in rabbit aorta.
    Lomholt M; Nedergaard OA
    Pharmacol Toxicol; 2000 Jun; 86(6):264-9. PubMed ID: 10895989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.